Green Thumb Industries Inc(GTBIF)
USD --+0.00%
Reward50Moderate
Risk44Moderate
📊75%Data
Thin 4% profit margin
GTBIF
+0.0 · +0.00%
USD · OTCQX
Green Thumb Industries Inc | Healthcare
Balanced
Market Cap:1.51Bn
ℹ️
Reward Rating
50
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
44
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on GTBIF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $13.63.

What is Green Thumb Industries Inc?

manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTBIF · Verdict

Moderate reward · moderate risk

GTBIF's standout is cash flow; growth and balance sheet weigh on the picture.

Based on 88% data coverage

GTBIF · Verdict

What’s working & what to watch

Strengths 1

  • Cash flow75/100

    10% free-cash-flow margin

Watchouts 2

  • Growth42/100

    Rev +8.4% CAGR · earnings -1.1%

  • Balance sheet45/100

    Current ratio 2.45

Model-based scoring. For information only — not financial advice.

What is Green Thumb Industries Inc?

manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company is listed on the OTCQX in USA, operating in the Healthcare sector, with a market capitalisation of 1.51B, and a P/E ratio of 38.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (50)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.51B
P/E Ratio38.3529
Dividend YieldN/A
52 Week High10.43
52 Week Low4.63
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding207M
No. of Employees4,800
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTCQX
Beta0.916
CurrencyUSD